Skip to main content
Medicure Inc logo

Medicure Inc — Investor Relations & Filings

Ticker · MPH ISIN · CA58469E4085 LEI · 9845007T999BF377B627 TSXV Manufacturing
Open in API
Filings indexed 293 across all filing types
Latest filing 2025-08-20 Regulatory Filings
Country CA Canada
Listing TSXV MPH

About Medicure Inc

https://www.medicure.com/

Medicure Inc. is a value-based pharmaceutical company specializing in the research, clinical development, and commercialization of human therapeutics. The company is primarily focused on developing and commercializing innovative and affordable medicines within the cardiovascular therapeutic area. Medicure's core mission is to serve patients by delivering safe and efficacious life-changing medicines, with a strategic focus on the U.S. market. It aims to offer a growing portfolio of products and services, ensuring patient access to necessary care.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 85% confidence The document is a NI 52-109FV2 ‘Certification of Interim Filings’ by the CEO, which is a regulatory form certifying the interim financial report and MD&A. It is not the interim report itself (IR) nor an announcement of publication (RPA), but rather a required regulatory certification filing that does not fit any specialized category. Therefore it falls under the fallback category Regulatory Filings (RNS).
2025-08-20 English
News release - English.pdf
Earnings Release Classification · 92% confidence The document is a press release announcing Medicure’s financial results for the quarter ended June 30, 2025. It includes key revenue and net loss highlights, adjusted EBITDA figures, summarized financial tables, and conference call details. This format and content are characteristic of an initial quarterly earnings announcement rather than a full interim report or annual filing. Q2 2025
2025-08-20 English
News release - English.pdf
Regulatory Filings
2025-08-18 English
News release - English.pdf
M&A Activity Classification · 95% confidence The document is a press release announcing the closing of an acquisition of West Olympia Pharmacy, detailing the transaction, strategic rationale, and financial impact. It is an M&A announcement rather than an annual or interim report, earnings release, or governance notice. Therefore, it fits the M&A Activity category.
2025-06-17 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Consolidated Interim Financial Statements' for Medicure Inc. for the three months ended March 31, 2025. It contains comprehensive financial statements (Statement of Financial Position, Statement of Net Income, Statement of Changes in Equity, Statement of Cash Flows) and detailed explanatory notes. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data for a period shorter than a full fiscal year. Q1 2025
2025-05-21 English
Interim MD&A - English.pdf
Management Reports Classification · 87% confidence The document is titled “Management’s Discussion and Analysis for the three months ended March 31, 2025” and contains the MD&A section with forward-looking statements, business overview, results commentary and outlook for an interim period. It is a standalone management discussion rather than a full annual report or earnings release, matching the “Management Reports” definition (Code: MDA).
2025-05-21 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.